Timothy A Lin (Timothy Lin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Locally Advanced

Liver Metastases

Top Venues

Cancer research communications

Translational andrology and urology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist (2024)
Timothy A Lin, Daniel Y Song
European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy. Translational andrology and urology 13 (4) (2024)
Alexander D Sherry, Timothy A Lin, Zachary Ryan McCaw, Esther J Beck, Ramez Kouzy, Joseph Abi Jaoude, Adina H Passy, Avital M Miller, Gabrielle S Kupferman, Clifton David Fuller, Charles R Thomas, Eugene Jon Koay, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials. International journal of cancer (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist 29 (7) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary endpoint utilization and publication rate among phase III oncology trials. Cancer research communications (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist 29 (7) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Timothy A Lin, Zachary Ryan McCaw, Alex Koong, Christine Lin, Joseph Abi Jaoude, Roshal R Patel, Ramez Kouzy, Molly B El Alam, Alexander D Sherry, Sonal S Noticewala, Clifton David Fuller, Charles R Thomas, Ryan Sun, Jiun-Kae Jack Lee, Ruitao Lin, Ying Yuan, Yu Shyr, Tomer Meirson, Ethan Bernard Ludmir
Proportional Hazards Violations in Phase 3 Cancer Clinical Trials: A Potential Source of Trial Misinterpretation. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist 29 (7) (2024)
Alexander D Sherry, Adina H Passy, Zachary Ryan McCaw, Joseph Abi Jaoude, Timothy A Lin, Ramez Kouzy, Avital M Miller, Gabrielle S Kupferman, Esther J Beck, Pavlos Msaouel, Ethan Bernard Ludmir
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses. JCO clinical cancer informatics 8 (2024)
Timothy A Lin, Daniel Y Song
European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy. Translational andrology and urology 13 (4) (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist (2024)
Timothy A Lin, Abhinav Reddy, Colin Hill, Shuchi Sehgal, Jin He, Lei Zheng, Joseph Herman, Jeffrey Meyer, Amol Narang
The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer. Cancers 15 (4) (2023)
Timothy A Lin, Abhinav Reddy, Colin Hill, Shuchi Sehgal, Jin He, Lei Zheng, Joseph Herman, Jeffrey Meyer, Amol Narang
The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer. Cancers 15 (4) (2023)
Timothy A Lin, Ananya Das, Zachary Ryan McCaw, Ethan Bernard Ludmir
Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Timothy A Lin, Clifton David Fuller, Vivek Verma, Walker Mainwaring, Andres F Espinoza, Austin B Miller, Amit Jethanandani, Dario Pasalic, Prajnan Das, Bruce D Minsky, Charles R Thomas, David R Fogelman, Vivek Subbiah, Ishwaria M Subbiah, Ethan Bernard Ludmir
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers 12 (9) (2020)
Timothy A Lin, Ethan Bernard Ludmir, Kai-Ping Liao, Mary Frances McAleer, Andrew J Bishop, David Grosshans, Susan McGovern, Kristina D Woodhouse, Arnold C Paulino, Debra Nana Yeboa
Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatric blood & cancer 67 (11) (2020)